ZFA-91004-17687
3 vaccinations
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 12-15
- ZIP prefix
- 024 / MA
- Registered
- 2022-06-26
- Relationship
- Child or adolescent in my care
- Guardian
- 2QU-20739-54270
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-13
Dose 1 — Pfizer-BioNTech
-
2021-06-05
Dose 2 — Pfizer-BioNTech
-
2022-01-07
Dose 3 — Pfizer-BioNTech
-
2022-06-26
Registered in v-safe
-
2022-07-10
Survey response — 6 months, dose 3, dependentMedDRA: Headache, Pre-existing disease, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Post covid. Headaches and congestion.MedDRA releases: 2024-11 · check-in free text available
- 2023-01-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-13 | Pfizer-BioNTech | No |
| 2 | 2021-06-05 | Pfizer-BioNTech | No |
| 3 | 2022-01-07 | Pfizer-BioNTech | No |
Free text
Release 12 — 6 months, dose 3, dependent
Symptoms: Post covid. Headaches and congestion.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release